Grace Therapeutics grants 35,760 options to VP
Grace Therapeutics, Inc. (GRCE) reported that officer Kumar Amresh, VP Program Management, received a grant of stock options for 35,760 shares of common stock on 2026-08-28.
Rhea-AI Filing Summary
Grace Therapeutics, Inc. (GRCE) reported that officer Kumar Amresh, VP Program Management, received a grant of stock options for 35,760 shares of common stock on 2026-08-28. The options have an exercise price of $2.12 per share and expire on 2036-08-27, with post-grant holdings of 35,760 options.
According to the award terms, the options vest quarterly in substantially equal installments over three years, with 1/12 vesting immediately on the grant date and the remaining 11/12 vesting over the following 11 quarters, subject to Mr. Amresh’s continuous service.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 35,760 shares
Grant/Award
1 txn
Insider
Kumar Amresh
Role
VP Program Management
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F1 | 35,760 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 35,760 contracts (Direct)
Footnotes (1)
- F1. These options vest quarterly in substantially equal installments over a three-year period, subject to the Reporting Person's continuous service as of each vesting date, The first 1/12 tranche shall vest immediately upon the grant date with the remaining 11/12 vesting equally over the following 11 quarters starting on the three-month anniversary of the grant date.
Key Figures
Stock options granted: 35,760 options
Exercise price: $2.12 per share
Underlying common shares: 35,760 shares
+3 more
6 metrics
Stock options granted
35,760 options
Grant to Kumar Amresh on 2026-08-28
Exercise price
$2.12 per share
Exercise price for granted stock options
Underlying common shares
35,760 shares
Shares of Grace Therapeutics common stock underlying the options
Post-transaction option holdings
35,760 options
Total options held by Kumar Amresh after this grant
Expiration date
2036-08-27
Expiration of granted stock options
Immediate vesting tranche
1/12 of options
Vests on the grant date, with remaining 11/12 over 11 quarters
Key Terms
Stock Option (Right to Buy), exercise price, vesting, Common Stock
4 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
exercise price financial
"conversion_or_exercise_price: "2.1200""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"These options vest quarterly in substantially equal installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Common Stock financial
"underlying_security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
What type of insider transaction was reported for GRCE?
The filing reports a grant of stock options to officer Kumar Amresh. He acquired 35,760 options to buy Grace Therapeutics common stock as part of compensation, not through an open-market purchase.
How many stock options did Kumar Amresh receive from Grace Therapeutics (GRCE)?
Kumar Amresh received 35,760 stock options, each representing the right to buy one share of Grace Therapeutics common stock. Following this grant, his reported holdings in this option award total 35,760 options.
What is the exercise price of the GRCE options granted to Kumar Amresh?
The options granted to Kumar Amresh have an exercise price of $2.12 per share. This is the price he would pay per share to convert the options into Grace Therapeutics common stock when exercising them.
When do the newly granted GRCE stock options to Kumar Amresh vest?
The options vest quarterly over three years. 1/12 vests immediately on the grant date, and the remaining 11/12 vest equally over the next 11 quarters, contingent on his continued service.
When do the GRCE stock options granted to Kumar Amresh expire?
The stock options granted to Kumar Amresh expire on 2036-08-27, giving him roughly a ten-year period from grant to exercise vested options at the $2.12 per share exercise price.
AI-generated analysis. How Rhea-AI works. Not financial advice.
